Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11001897 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: L-NMMA;   Drug: Acetylcholine
2 Completed
Has Results
Simvastatin (Zocor) Therapy in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Simvastatin

Indicates status has not been verified in more than two years